|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000177494 |
Summary for ZBED2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000177494 | Gene symbol | ZBED2 |
| Gene name | zinc finger BED-type containing 2 | |
| HGNC | 20710 | |
| Entrez ID | 79413 | |
| Gene type | protein_coding | |
| Synonyms | ZBED2|MGC10796 | |
| UniProtAcc | Q9BTP6 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ZBED2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ZBED2 | 1.17e+02 | -1.08e+00 | 3.11e-01 | -3.46e+00 | 5.31e-04 | 3.33e-03 | KIRP |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ZBED2 | 2.72e+02 | 4.29e+00 | 7.67e-01 | 5.60e+00 | 2.17e-08 | 2.58e-07 | BLCA |
| ZBED2 | 5.68e+02 | 3.43e+00 | 7.56e-01 | 4.54e+00 | 5.64e-06 | 9.92e-05 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for ZBED2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ZBED2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg23670794 | chr3:111594218 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 6.44e-01 | 5.14e-01 | 4.42e+00 | 1.01e-05 | 1.10e-04 | 1.31e-01 |
| LIHC | cg25298754 | chr3:111595255 | CGI:chr3:111674480-111674697 | promoter,gene body | 6.09e-01 | 4.89e-01 | 4.46e+00 | 8.38e-06 | 9.40e-05 | 1.20e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg23670794 | chr3:111594218 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 3.62e-01 | 4.83e-01 | -2.33e+00 | 1.98e-02 | 2.29e-02 | -1.21e-01 |
| HNSC | cg25298754 | chr3:111595255 | CGI:chr3:111674480-111674697 | promoter,gene body | 2.90e-01 | 4.14e-01 | -2.62e+00 | 8.80e-03 | 1.15e-02 | -1.23e-01 |
| LUSC | cg23670794 | chr3:111594218 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 5.56e-01 | 7.55e-01 | -2.95e+00 | 3.19e-03 | 5.86e-03 | -1.99e-01 |
| LUSC | cg25298754 | chr3:111595255 | CGI:chr3:111674480-111674697 | promoter,gene body | 4.08e-01 | 5.25e-01 | -2.60e+00 | 9.45e-03 | 1.33e-02 | -1.17e-01 |
| LUSC | cg24323726 | chr3:111595339 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 4.29e-01 | 5.42e-01 | -2.89e+00 | 3.83e-03 | 6.69e-03 | -1.13e-01 |
| COAD | cg24323726 | chr3:111595339 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 6.20e-01 | 7.32e-01 | -2.25e+00 | 2.44e-02 | 2.89e-02 | -1.12e-01 |
| BLCA | cg25298754 | chr3:111595255 | CGI:chr3:111674480-111674697 | promoter,gene body | 5.97e-01 | 8.41e-01 | -3.59e+00 | 3.36e-04 | 9.79e-04 | -2.44e-01 |
| BLCA | cg24323726 | chr3:111595339 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 6.10e-01 | 7.90e-01 | -3.09e+00 | 1.98e-03 | 3.89e-03 | -1.81e-01 |
| ESCA | cg24323726 | chr3:111595339 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 4.76e-01 | 6.59e-01 | -2.17e+00 | 2.97e-02 | 4.37e-02 | -1.83e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg23670794 | chr3:111594218 | CGI:chr3:111674480-111674697 | UTR,promoter,exon,gene body | 7.24e-01 | 9.09e-01 | -1.05e+01 | 7.58e-26 | 6.99e-25 | -1.85e-01 |
| BRCA | cg25298754 | chr3:111595255 | CGI:chr3:111674480-111674697 | promoter,gene body | 6.37e-01 | 7.67e-01 | -5.79e+00 | 6.84e-09 | 1.55e-08 | -1.30e-01 |
Top |
Exon skipping events with PSI in TCGA for ZBED2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ZBED2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ZBED2 |
| TFs related to ZBED2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | FOXR2 | ZBED2 | 4.94e+00 | 9.96e-01 | 3.52e+00 | 1.65e-03 | Male-biased |
| CHOL | MSX1 | ZBED2 | 5.52e+00 | 9.91e-01 | 4.46e+00 | 7.48e-03 | Male-biased |
| CHOL | MSX2 | ZBED2 | 5.44e+00 | 9.90e-01 | 4.43e+00 | 8.89e-03 | Male-biased |
| CHOL | POU3F3 | ZBED2 | 5.40e+00 | 9.94e-01 | 4.21e+00 | 4.42e-03 | Male-biased |
| CHOL | POU4F1 | ZBED2 | 5.47e+00 | 9.94e-01 | 4.28e+00 | 4.32e-03 | Male-biased |
| CHOL | ZNF713 | ZBED2 | 5.20e+00 | 9.83e-01 | 4.32e+00 | 1.46e-02 | Male-biased |
| CHOL | ZNF716 | ZBED2 | 5.08e+00 | 9.92e-01 | 3.95e+00 | 5.61e-03 | Male-biased |
| CHOL | ZNF79 | ZBED2 | 4.89e+00 | 9.96e-01 | 3.42e+00 | 1.32e-03 | Male-biased |
| DLBC | ARGFX | ZBED2 | 5.90e+00 | 9.96e-01 | 4.76e+00 | 3.53e-03 | Male-biased |
| DLBC | FOXR2 | ZBED2 | 4.27e+00 | 9.90e-01 | 2.15e+00 | 1.29e-04 | Male-biased |
| DLBC | ISX | ZBED2 | 5.86e+00 | 9.96e-01 | 4.70e+00 | 3.21e-03 | Male-biased |
| DLBC | MSX1 | ZBED2 | 5.37e+00 | 9.95e-01 | 4.16e+00 | 2.76e-03 | Male-biased |
| DLBC | MSX2 | ZBED2 | 5.26e+00 | 9.96e-01 | 4.02e+00 | 2.39e-03 | Male-biased |
| DLBC | PBX4 | ZBED2 | 5.94e+00 | 9.86e-01 | 5.15e+00 | 1.35e-02 | Male-biased |
| DLBC | POU3F3 | ZBED2 | 4.97e+00 | 9.96e-01 | 3.28e+00 | 5.15e-04 | Male-biased |
| DLBC | POU4F1 | ZBED2 | 5.18e+00 | 9.95e-01 | 4.02e+00 | 3.12e-03 | Male-biased |
| DLBC | SNAI1 | ZBED2 | 3.07e+00 | 5.26e-03 | 4.13e+00 | 9.83e-01 | Female-biased |
| DLBC | ZNF677 | ZBED2 | 4.38e+00 | 9.90e-01 | 3.03e+00 | 1.55e-03 | Male-biased |
| DLBC | ZNF713 | ZBED2 | 5.10e+00 | 9.86e-01 | 4.26e+00 | 1.12e-02 | Male-biased |
| DLBC | ZNF716 | ZBED2 | 4.59e+00 | 9.93e-01 | 3.12e+00 | 1.01e-03 | Male-biased |
| DLBC | ZNF79 | ZBED2 | 4.19e+00 | 9.89e-01 | 1.94e+00 | 8.82e-05 | Male-biased |
| DLBC | ZSCAN23 | ZBED2 | 5.86e+00 | 9.84e-01 | 5.10e+00 | 1.50e-02 | Male-biased |
| ESCA | ARGFX | ZBED2 | 5.78e+00 | 9.88e-01 | 5.07e+00 | 1.05e-02 | Male-biased |
| ESCA | DLX3 | ZBED2 | 5.98e+00 | 9.86e-01 | 5.30e+00 | 1.30e-02 | Male-biased |
| ESCA | FOXR2 | ZBED2 | 4.39e+00 | 9.90e-01 | 3.46e+00 | 3.05e-03 | Male-biased |
| ESCA | ISX | ZBED2 | 5.84e+00 | 9.92e-01 | 5.05e+00 | 6.73e-03 | Male-biased |
| ESCA | MSX1 | ZBED2 | 5.26e+00 | 9.86e-01 | 4.57e+00 | 1.20e-02 | Male-biased |
| ESCA | MSX2 | ZBED2 | 5.22e+00 | 9.89e-01 | 4.48e+00 | 8.74e-03 | Male-biased |
| ESCA | PBX4 | ZBED2 | 5.71e+00 | 9.90e-01 | 4.97e+00 | 8.80e-03 | Male-biased |
| ESCA | POU3F3 | ZBED2 | 5.00e+00 | 9.92e-01 | 4.15e+00 | 4.91e-03 | Male-biased |
| ESCA | POU4F1 | ZBED2 | 5.28e+00 | 9.84e-01 | 4.62e+00 | 1.41e-02 | Male-biased |
| ESCA | ZNF33A | ZBED2 | 2.36e+00 | 6.65e-04 | 3.72e+00 | 9.82e-01 | Female-biased |
| MESO | FOXR2 | ZBED2 | 4.32e+00 | 6.15e-03 | 5.76e+00 | 9.93e-01 | Female-biased |
| MESO | POU3F3 | ZBED2 | 4.69e+00 | 9.34e-03 | 6.00e+00 | 9.90e-01 | Female-biased |
| MESO | ZNF79 | ZBED2 | 4.29e+00 | 4.27e-03 | 5.84e+00 | 9.95e-01 | Female-biased |
| PCPG | ARGFX | ZBED2 | 5.44e+00 | 9.91e-01 | 4.54e+00 | 6.82e-03 | Male-biased |
| PCPG | FOXR2 | ZBED2 | 3.96e+00 | 9.83e-01 | 2.56e+00 | 5.41e-04 | Male-biased |
| PCPG | HSFY2 | ZBED2 | 5.40e+00 | 9.85e-01 | 4.66e+00 | 1.32e-02 | Male-biased |
| PCPG | ISX | ZBED2 | 5.44e+00 | 9.95e-01 | 4.39e+00 | 3.32e-03 | Male-biased |
| PCPG | MSX1 | ZBED2 | 4.83e+00 | 9.92e-01 | 3.80e+00 | 3.67e-03 | Male-biased |
| PCPG | MSX2 | ZBED2 | 4.82e+00 | 9.92e-01 | 3.77e+00 | 3.26e-03 | Male-biased |
| PCPG | PBX4 | ZBED2 | 5.38e+00 | 9.90e-01 | 4.54e+00 | 8.57e-03 | Male-biased |
| PCPG | POU3F3 | ZBED2 | 4.59e+00 | 9.93e-01 | 3.28e+00 | 9.16e-04 | Male-biased |
| PCPG | POU4F1 | ZBED2 | 4.92e+00 | 9.94e-01 | 3.77e+00 | 2.06e-03 | Male-biased |
| PCPG | SNAI1 | ZBED2 | 2.73e+00 | 6.24e-04 | 4.12e+00 | 9.88e-01 | Female-biased |
| PCPG | ZNF281 | ZBED2 | 2.30e+00 | 2.25e-04 | 3.90e+00 | 9.84e-01 | Female-biased |
| PCPG | ZNF341 | ZBED2 | 2.61e+00 | 1.35e-03 | 3.84e+00 | 9.81e-01 | Female-biased |
| PCPG | ZNF444 | ZBED2 | 2.37e+00 | 3.44e-04 | 3.88e+00 | 9.83e-01 | Female-biased |
| PCPG | ZNF468 | ZBED2 | 2.40e+00 | 2.94e-04 | 3.94e+00 | 9.85e-01 | Female-biased |
| PCPG | ZNF554 | ZBED2 | 2.75e+00 | 6.09e-04 | 4.15e+00 | 9.89e-01 | Female-biased |
| PCPG | ZNF713 | ZBED2 | 4.62e+00 | 9.84e-01 | 3.82e+00 | 1.02e-02 | Male-biased |
| PCPG | ZNF716 | ZBED2 | 4.22e+00 | 9.84e-01 | 3.27e+00 | 5.11e-03 | Male-biased |
| PCPG | ZNF740 | ZBED2 | 2.60e+00 | 4.97e-04 | 4.03e+00 | 9.87e-01 | Female-biased |
| PCPG | ZNF79 | ZBED2 | 3.85e+00 | 9.80e-01 | 2.50e+00 | 6.61e-04 | Male-biased |
| PCPG | ZSCAN30 | ZBED2 | 2.46e+00 | 1.95e-04 | 4.09e+00 | 9.88e-01 | Female-biased |
| SARC | TOPORS | ZBED2 | 4.31e+00 | 9.80e-01 | 3.75e+00 | 9.86e-03 | Male-biased |
| SARC | ZNF121 | ZBED2 | 4.66e+00 | 9.93e-01 | 3.71e+00 | 1.06e-03 | Male-biased |
| SARC | ZNF181 | ZBED2 | 4.67e+00 | 9.93e-01 | 3.76e+00 | 1.38e-03 | Male-biased |
| SARC | ZNF235 | ZBED2 | 4.40e+00 | 9.89e-01 | 3.63e+00 | 2.87e-03 | Male-biased |
| SARC | ZNF287 | ZBED2 | 4.12e+00 | 9.83e-01 | 3.40e+00 | 3.71e-03 | Male-biased |
| SARC | ZNF33A | ZBED2 | 4.69e+00 | 9.94e-01 | 3.72e+00 | 9.62e-04 | Male-biased |
| SARC | ZNF443 | ZBED2 | 4.90e+00 | 9.95e-01 | 3.95e+00 | 1.05e-03 | Male-biased |
| SKCM | ARGFX | ZBED2 | 5.11e+00 | 1.15e-02 | 6.05e+00 | 9.87e-01 | Female-biased |
| SKCM | FOXR2 | ZBED2 | 3.25e+00 | 2.07e-03 | 4.73e+00 | 9.88e-01 | Female-biased |
| SKCM | ISX | ZBED2 | 4.98e+00 | 1.13e-02 | 5.92e+00 | 9.87e-01 | Female-biased |
| SKCM | MSX1 | ZBED2 | 4.46e+00 | 7.30e-03 | 5.54e+00 | 9.90e-01 | Female-biased |
| SKCM | MSX2 | ZBED2 | 4.35e+00 | 6.87e-03 | 5.45e+00 | 9.90e-01 | Female-biased |
| SKCM | PBX4 | ZBED2 | 5.05e+00 | 1.46e-02 | 5.91e+00 | 9.84e-01 | Female-biased |
| SKCM | POU3F3 | ZBED2 | 4.03e+00 | 4.15e-03 | 5.30e+00 | 9.92e-01 | Female-biased |
| SKCM | POU4F1 | ZBED2 | 4.38e+00 | 7.91e-03 | 5.44e+00 | 9.89e-01 | Female-biased |
| SKCM | ZNF716 | ZBED2 | 3.87e+00 | 7.29e-03 | 4.95e+00 | 9.85e-01 | Female-biased |
| SKCM | ZNF79 | ZBED2 | 3.19e+00 | 1.78e-03 | 4.71e+00 | 9.88e-01 | Female-biased |
| ZBED2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ZBED2 |
| RBPs related to ES in ZBED2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ZBED2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4682422 | chr3:112759877:A:G | - | 0.156127755760101 | 0.038434056209339 | LUSC | Female-baised eQTL |
| rs79029293 | chr3:118538421:T:C | - | 0.209303306165858 | 0.0182136399280129 | BLCA | Female-baised eQTL |
| rs80054479 | chr3:118618921:T:C | - | 0.212792605848967 | 0.0449613143558171 | BLCA | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs61797775 | chr3:120257317:A:G | - | 0.0732974480821455 | 0.00640035329097754 | LUSC | Male-baised eQTL |
| rs28495065 | chr3:120258800:A:G | - | 0.0704513322540051 | 0.0114331375570716 | LUSC | Male-baised eQTL |
| rs9811713 | chr3:120248592:C:T | - | 0.0679727363881611 | 0.0177693636737144 | LUSC | Male-baised eQTL |
| rs6438275 | chr3:115611416:A:G | - | -0.0810404026742623 | 0.048755315104507 | BLCA | Male-baised eQTL |
| rs6764017 | chr3:110660988:C:T | - | 0.101566548500172 | 0.0326375711999925 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ZBED2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
